Technology-assisted locomotion therapy in people with residual gait impairment after a neurological event

Technology-assisted locomotion therapy in people with residual gait impairment after a neurological event - REMO

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022766

Enrollment

Registered

2020-07-31

Start date

2021-03-17

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I63.9 S14

Interventions

Group 1: After inclusion and baseline assessments (10MWT, PGIC, FAC, TUG, 6 MWT, L-Force Test), each participant will undergo standard technology-based locomotion training which is offered at Revigo.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Residual gait impairment after neurological event, medical clearance for technology-based gait training, good communication skills in German, subscription to Revigo for duration of study participation (with financial contribution from insurance and Revigo), signed informed written consent

Exclusion criteria

Exclusion criteria: ongoing in-patient rehabilitation, neuro-psychological impairments, including cognitive deficits, that make communication and cooperation impossible, diagnosis of multiple sclerosis or Parkinson’s disease, pregnancy

Design outcomes

Primary

Measure	Time frame
The primary objective of this study is to determine if a three months technology-based gait training will lead to functional improvements (determined using 10 MWT). The 10 MWT will be assessed at baseline, after 3 months and for some participants also after 6 months.	—

Secondary

Measure	Time frame
relevant improvements in gait ability. As secondary objective, the amount of performed trainings, general health (including quality of life), as well as costs associated with the training will be assessed. The following assessments will be used: PGIC, FAC, TUG, L-Force-TEst, WHODAS, EQ-5D, amount of trainings, willingness to pay, costs. The assessments will be assessed at baseline, after 3 months and for some participants also after 6 months.	—

Measure

Time frame

relevant improvements in gait ability. As secondary objective, the amount of performed trainings, general health (including quality of life), as well as costs associated with the training will be assessed. The following assessments will be used: PGIC, FAC, TUG, L-Force-TEst, WHODAS, EQ-5D, amount of trainings, willingness to pay, costs. The assessments will be assessed at baseline, after 3 months and for some participants also after 6 months.

—

Countries

Switzerland

Contacts

Public ContactDino de Bon

Revigo

d.debon@revigo.ch+41 58 206 08 40

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026